Human leukocyte antigen-specific antibodies and gamma-interferon stimulate human microvascular and glomerular endothelial cells to produce complement factor C4
Hamer, Rizwan, Molostvov, Guerman, Lowe, David, Satchell, Simon, Mathieson, Peter, Ilyas, Rebecca, Mitchell, Daniel Anthony, Lam, For T., Kashi, Habib, Tan, Lam Chin, Imray, C. (Chris), Fletcher, Simon, Briggs, David, Krishnan, Nithya, Higgins, Robert and Zehnder, Daniel. (2012) Human leukocyte antigen-specific antibodies and gamma-interferon stimulate human microvascular and glomerular endothelial cells to produce complement factor C4. Transplantation, Vol.93 (No.9). pp. 867-873. ISSN 0041-1337Full text not available from this repository.
Official URL: http://dx.doi.org/10.1097/TP.0b013e31824b3762
Background: The role of the complement system in antibody-mediated rejection has been investigated in relation to circulating complement interacting with renal microvascular endothelium, resulting in the formation of peritubular capillary C4d. However, the possible importance of local complement synthesis is less clear. The aim of this study was to determine whether human vascular endothelium could produce C4 in response to stimulation in vitro. METHODS: Human microvascular endothelial cells and glomerular endothelial cells were stimulated with endotoxins, cytokines, and human leukocyte antigen-specific antibodies. Synthesis of complement was investigated using western blotting and indirect immunofluorescence. De novo C4 synthesis was confirmed by using C4 small interfering RNA. RESULTS: Glomerular and microvascular endothelium, both produce C3 and C4 complement protein. Complement synthesis was stimulant-specific-C3 was produced mainly after stimulation with lipopolysaccharide whereas C4 synthesis occurred on treatment with gamma interferon. Culture with human leukocyte antigen-specific antibodies resulted in a significant increase of C4 protein synthesis by both cell lines. CONCLUSIONS: We have shown for the first time that human microvascular endothelium can be stimulated to synthesize C4 in vitro. The implications of this for clinical transplantation, especially in the context of antibody-mediated rejection, its histological interpretation and as a potential target for therapy would have to be determined by further studies. © 2012 Lippincott Williams & Wilkins.
|Item Type:||Journal Article|
|Divisions:||Faculty of Medicine > Warwick Medical School > Clinical Sciences Research Institute (CSRI)
Faculty of Medicine > Warwick Medical School
|Journal or Publication Title:||Transplantation|
|Publisher:||Lippincott Williams & Wilkins|
|Official Date:||15 May 2012|
|Page Range:||pp. 867-873|
|Access rights to Published version:||Restricted or Subscription Access|
Actions (login required)